Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • News

Lightning eMotors Q2 GAAP EPS $(0.79) Down From $(0.10) YoY, Adj. Loss From Operations $8.7M, Sales $5.90M Beat $5.75M Estimate

By Benzinga Newsdesk
Today, 9:11 AM
Lightning eMotors (NYSE:ZEV) reported quarterly losses of $(0.79) per share. This is a 690 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $5.90

ZEV

Read More
1 minute read
  • Markets
  • Movers
  • Pre-Market Outlook

10 Industrials Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights
Today, 9:11 AM
 

BEST

Read More
8 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook

Earnings Scheduled For August 16, 2021

By Benzinga Insights
Today, 9:11 AM
  Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.

ACRX

Read More
1 minute read
  • Markets
  • Movers
  • Pre-Market Outlook

10 Industrials Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights
Today, 9:11 AM
 

BLBD

Read More
1 minute read
  • Media
  • Small Cap

Cramer Gives His Opinion On Zillow, SoFi And More

By Craig Jones
Today, 9:11 AM
On CNBC's "Mad Money Lightning Round," Jim Cramer said this is a decent level at which to buy Zillow Group Inc Class A (NASDAQ: ZG) with mortgage rates so low.

ATCX

Read More
2 minute read
  • Movers

Unusual Options Activity Insight: Lightning eMotors

By Benzinga Insights
Today, 9:11 AM
Shares of Lightning eMotors (NYSE:ZEV) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $10.59.

ZEV

Read More
8 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For August 11, 2021

By Benzinga Insights
Today, 9:11 AM
 

ABST

Read More
1 minute read
  • Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Wednesday, Aug. 11, 2021: XLK, ZEV, DYAI, FULC, BLNK

By Benzinga Newsdesk
Today, 9:11 AM
Today's 5 Stock Ideas:  SPDR Select Fund - Technology (XLK) - This ETF was indicated higher Wednesday morning following cooler-than-expected inflation data for the month of July. The month-over-month

BLNK

Read More
1 minute read
  • Markets
  • Movers
  • Pre-Market Outlook

12 Industrials Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights
Today, 9:11 AM
 

ATCX

Read More
7 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

85 Biggest Movers From Yesterday

By Lisa Levin
Today, 9:11 AM
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.

ABVC

Posts navigation

Previous 1 … 12 13 14 … 16 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service